The company said that it is going to consider a USD 1 billion contract for its drug unit sale, reports CNBC-TV18, quoting Agencies.
Moneycontrol News
@moneycontrolcom
Shares of Piramal Enterprises gained 4.3 percent intraday Tuesday as the company is considering selling of a drug unit.
The company said that it is going to consider a USD 1 billion contract for its drug unit sale, reported CNBC-TV18.
The company said that it will send out marking documents to the potential buyers, and expects to draw interest from PE funds and US firms.
First Published on Oct 16, 2018 02:24 pm
